Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
According to a superseding indictment unsealed in January 2024 by the U.S. Attorney's Office for the Eastern District of New ...
The investment seeks long-term total return. The fund will seek to achieve its investment objective by investing principally in a portfolio of residential and commercial mortgage-backed securities and ...
Kesimpta is a prescription medication used to treat clinically isolated syndrome (CIS) and relapsing forms of multiple sclerosis (MS). Kesimpta comes as a solution inside single-dose prefilled ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results